Evan Horn

Evan Horn has extensive work experience in the field of medicinal chemistry. Evan currently holds the position of Principal Scientist at Treeline Biosciences, a role they started in May 2021. Prior to that, Evan worked at Bristol Myers Squibb, where they held multiple roles including Principal Scientist, Senior Scientist, and Scientist II in the Medicinal Chemistry department. Evan joined Bristol Myers Squibb in November 2019 and worked there until May 2021. Before their time at Bristol Myers Squibb, Evan worked at Celgene as a Scientist II and Scientist I in the Medicinal Chemistry department from September 2016 to November 2019. Evan also has experience as a Postdoctoral Researcher at The Scripps Research Institute from August 2014 to September 2016. Evan began their career as a Medicinal Chemistry Intern at Gilead Sciences from June 2007 to September 2007. Overall, Evan's work experience showcases their expertise in medicinal chemistry and their progression to more senior roles in the field.

Evan Horn obtained a Bachelor's Degree in Chemistry from the University of California, Davis. Following this, they pursued a Doctor of Philosophy (Ph.D.) in Organic Chemistry at UC Irvine.